Supportive Care in Cancer

, Volume 25, Issue 12, pp 3683–3690 | Cite as

Assessing cancer-specific anxiety in Chinese men with prostate cancer: psychometric evaluation of the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC)

  • Qingmei Huang
  • Ping Jiang
  • Zijun Zhang
  • Jie Luo
  • Yun Dai
  • Li Zheng
  • Wei Wang
Original Article

Abstract

Purpose

The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) was developed to identify and assess cancer-specific anxiety among men with prostate cancer (PCa); however, there is no Chinese version. The aim of our study was to translate the English version of MAX-PC into Chinese and evaluate the psychometric properties of it.

Methods

The study cohort comprised 254 participants. Internal consistency including the Cronbach’s alpha coefficient and item–total correlations were used to measure the reliability of the scale. Factor structure was analyzed by exploratory factor analysis and concurrent validity by comparing MAX-PC scores with anxiety subscale scores of the Hospital Anxiety and Depression Scale (HADS). Divergent validity was assessed by correlating MAX-PC with HADS depression subscale, while discriminant ability by comparing differences in MAX-PC scores between different patient groups.

Results

The Chinese version of MAX-PC demonstrated good reliability; the Cronbach’s alpha coefficient for the total and three subscales (prostate cancer anxiety, PSA anxiety, and fear of recurrence) being 0.94, 0.93, 0.82, and 0.85, respectively. Exploratory factor analysis supported the three-factor structure of the scale established in the original version. Despite the somewhat underperformed divergent validity, the scale demonstrated good concurrent validity with a strong correlation with the HADS anxiety subscale (r = 0.71, p < 0.01). Moreover, discriminant ability was demonstrated by ability to differentiate between disease stages.

Conclusions

The MAX-PC Chinese version was confirmed to be a valid, reliable instrument and is thus appropriate for identifying and quantifying cancer-specific anxiety in Chinese PCa patients.

Keywords

Prostate cancer Cancer-specific anxiety Chinese men Psychometric evaluation 

Notes

Acknowledgements

We would like to thank Qiqi Mao, Xiangyi Zheng, Chenjuan Ma, Yuxiang Zhu, Ben Liu, Shaohua Hu for their contributions to translation and culture-adaptation of the scale. We also want to thank all the men with prostate cancer who participated in this study. The work was supported by Medical and Health Research project of Zhejiang province (2014ZDA009).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests.

Human and animal rights

The study was approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University

Informed consent

Informed consent was obtained from all individual participants included in the study, and written informed consents were obtained from all the participants.

References

  1. 1.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi: 10.1002/ijc.29210 CrossRefPubMedGoogle Scholar
  2. 2.
    Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics. CA Cancer J Clin 66(4):271–289. doi: 10.3322/caac.21349 CrossRefPubMedGoogle Scholar
  3. 3.
    Qi D, Wu C, Liu F, Gu K, Shi Z, Lin X, Tao S, Xu W, Brendler CB, Zheng Y, Xu J (2015) Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009. Prostate 75(14):1662–1668. doi: 10.1002/pros.23046 CrossRefPubMedGoogle Scholar
  4. 4.
    Ye D, Zhu Y (2015) Epidemiology of prostate cancer in China: an overview and clinical implication [article in Chinese]. Zhonghua Wai Ke Za Zhi 53(4):249–252PubMedGoogle Scholar
  5. 5.
    Darwish-Yassine M, Berenji M, Wing D, Copeland G, Demers RY, Garlinghouse C, Fagerlin A, Newth GE, Northouse L, Holmes-Rovner M, Rovner D, Sims J, Wei JT (2014) Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study. J Cancer Surviv 8(1):121–130. doi: 10.1007/s11764-013-0312-8 CrossRefPubMedGoogle Scholar
  6. 6.
    Parahoo K, McDonough S, McCaughan E, Noyes J, Semple C, Halstead EJ, Neuberger MM, Dahm P (2015) Psychosocial interventions for men with prostate cancer: a Cochrane systematic review. BJU Intl 116(2):174–183. doi: 10.1111/bju.12989 CrossRefGoogle Scholar
  7. 7.
    Ezer H, Chachamovich JR, Saad F, Aprikian A, Souhami L (2012) Psychosocial adjustment of men during the first year of prostate cancer. Cancer Nurs 35(2):141–147. doi: 10.1097/NCC.0b013e31821f1b81 CrossRefPubMedGoogle Scholar
  8. 8.
    O'Shaughnessy PK, Laws TA, Esterman AJ (2015) The prostate cancer journey: results of an online survey of men and their partners. Cancer Nurs 38(1):E1–E12. doi: 10.1097/NCC.0b013e31827df2a9 CrossRefPubMedGoogle Scholar
  9. 9.
    Nelson CJ, Balk EM, Roth AJ (2010) Distress, anxiety, depression, and emotional well-being in African-American men with prostate cancer. Psycho-Oncology 19(10):1052–1060. doi: 10.1002/pon.1659 CrossRefPubMedGoogle Scholar
  10. 10.
    Bisson JI, Chubb HL, Bennett S, Mason M, Jones D, Kynaston H (2002) The prevalence and predictors of psychological distress in patients with early localized prostate cancer. BJU Int 90(1):56–61CrossRefPubMedGoogle Scholar
  11. 11.
    Balderson N, Towell T (2003) The prevalence and predictors of psychological distress in men with prostate cancer who are seeking support. Br J Health Psychol 8(Pt2):125–134. doi: 10.1348/135910703321649114 CrossRefPubMedGoogle Scholar
  12. 12.
    Watson E, Shinkins B, Frith E, Neal D, Hamdy F, Walter F, Weller D, Wilkinson C, Faithfull S, Wolstenholme J, Sooriakumaran P, Kastner C, Campbell C, Neal R, Butcher H, Matthews M, Perera R, Rose P (2016) Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. BJU Int 117(6B):E10–E19. doi: 10.1111/bju.13122 CrossRefPubMedGoogle Scholar
  13. 13.
    Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, Lewith G (2014) Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 4(3):e003901. doi: 10.1136/bmjopen-2013-003901 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, Morgans AK, Penson DF (2015) Prostate Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol 33(9):1078–1085. doi: 10.1200/JCO.2014.60.2557 CrossRefPubMedGoogle Scholar
  15. 15.
    Choi EP, Wong CK, Tsu JH, Chin WY, Kung K, Wong CK, Yiu MK (2016) Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations. Support Care Cancer 24(4):1849–1856. doi: 10.1007/s00520-015-2980-6 CrossRefPubMedGoogle Scholar
  16. 16.
    Saini A, Berruti A, Cracco C, Sguazzotti E, Porpiglia F, Russo L, Bertaglia V, Picci RL, Negro M, Tosco A, Campagna S, Scarpa RM, Dogliotti L, Furlan PM, Ostacoli L (2013) Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. Urol Oncol 31(3):352–358. doi: 10.1016/j.urolonc.2011.02.005 CrossRefPubMedGoogle Scholar
  17. 17.
    Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17):1591–1597CrossRefPubMedGoogle Scholar
  18. 18.
    Roth A, Passik S (1996) Anxiety in men with prostate cancer may interfere with effective management of the disease. Prim Care Cancer 16:30–37Google Scholar
  19. 19.
    Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W (2003) The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 97(11):2910–2918. doi: 10.1002/cncr.11386 CrossRefPubMedGoogle Scholar
  20. 20.
    Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O'Shea N, Scher H, Holland JC, Slovin S, Curley-Smart T, Reynolds T, Breitbart W (2006) Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the memorial anxiety scale for prostate cancer (MAX–PC). Psychosomatics 47(4):340–347. doi: 10.1176/appi.psy.47.4.340 CrossRefPubMedGoogle Scholar
  21. 21.
    Nelson CJ, Starr TD, Macchia RJ, Hyacinthe L, Friedman S, Roth AJ (2016) Assessing anxiety in black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Support Care Cancer 24(7):2905–2911. doi: 10.1007/s00520-016-3092-7 PubMedPubMedCentralGoogle Scholar
  22. 22.
    Dale W, Hemmerich J, Meltzer D (2007) Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psycho-Oncology 16(5):493–498. doi: 10.1002/pon.1107 CrossRefPubMedGoogle Scholar
  23. 23.
    van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot ML (2009) Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer. Qual Life Res 18(8):1061–1066. doi: 10.1007/s11136-009-9516-9 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Stern AF (2014) The Hospital Anxiety and Depression Scale. Occup Med (Lond) 64(5):393–394. doi: 10.1093/occmed/kqu024 CrossRefGoogle Scholar
  25. 25.
    Roberts MH, Fletcher RB, Merrick PL (2014) The validity and clinical utility of the Hospital Anxiety and Depression Scale (HADS) with older adult New Zealanders. Int Psychogeriatr 26(2):325–333. doi: 10.1017/S104161021300197X CrossRefPubMedGoogle Scholar
  26. 26.
    Walker J, Postma K, McHugh GS, Rush R, Coyle B, Strong V, Sharpe M (2007) Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 63(1):83–91. doi: 10.1016/j.jpsychores.2007.01.009 CrossRefPubMedGoogle Scholar
  27. 27.
    Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19(12):1899–1908. doi: 10.1007/s00520-011-1251-4 CrossRefPubMedGoogle Scholar
  28. 28.
    Lynn MR (1986) Determination and quantification of content validity. Nurs Res 35(6):382–385CrossRefPubMedGoogle Scholar
  29. 29.
    Segrin C, Badger TA, Figueredo AJ (2011) Stage of disease progression moderates the association between social support and depression in prostate cancer survivors. J Psychosoc Oncol 29(5):552–560. doi: 10.1080/07347332.2011.599362 CrossRefPubMedGoogle Scholar
  30. 30.
    Couper JW, Love AW, Duchesne GM, Bloch S, Macvean M, Dunai JV, Scealy M, Costello A, Kissane DW (2010) Predictors of psychosocial distress 12 months after diagnosis with early and advanced prostate cancer. Med J Aust 193(5 Suppl):S58–S61PubMedGoogle Scholar
  31. 31.
    (2012) Ending violence against doctors in China. Lancet 379(9828): 1764. doi:  10.1016/S0140-6736(12)60729-6.
  32. 32.
    Jingang A (2013) Which future for doctors in China? Lancet 382(9896):936–937. doi: 10.1016/S0140-6736(13)61928-5 CrossRefPubMedGoogle Scholar
  33. 33.
    Tucker JD, Cheng Y, Wong B, Gong N, Nie JB, Zhu W, McLaughlin MM, Xie R, Deng Y, Huang M, Wong WC, Lan P, Liu H, Miao W, Kleinman A, Patient-Physician Trust Project Team (2015) Patient–physician mistrust and violence against physicians in Guangdong Province, China: a qualitative study. BMJ Open 5(10):e008221. doi: 10.1136/bmjopen-2015-008221 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Qingmei Huang
    • 1
  • Ping Jiang
    • 1
  • Zijun Zhang
    • 1
  • Jie Luo
    • 1
  • Yun Dai
    • 1
  • Li Zheng
    • 1
  • Wei Wang
    • 1
  1. 1.Department of Urology, The First Affiliated Hospital, College of MedicineZhejiang UniversityHangzhouChina

Personalised recommendations